(Total Views: 638)
Posted On: 06/13/2019 9:25:41 AM
Post# of 154911

$CYDY News Article - CytoDyn to Present Pivotal Data at ASM Microbe 2019 Demonstrating Efficacy and Safety of Leronlimab (PRO 140) in HIV Patients with Multiple ARV Class Resistance https://marketwirenews.com/news-releases/cyto...49344.html


My Twitter: WhyteStocks